Addison Advisors LLC reduced its stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 2.4% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 4,519 shares of the company’s stock after selling 109 shares during the period. Addison Advisors LLC’s […]
AJOVista LLC purchased a new stake in AbbVie Inc. (NYSE:ABBV – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 1,611 shares of the company’s stock, valued at approximately $250,000. Other hedge funds and other institutional investors have […]
Anchor Capital Advisors LLC decreased its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 1.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 107,216 shares of the company’s stock after selling 1,673 shares during the quarter. Anchor Capital Advisors LLC’s holdings […]
Consolidated Planning Corp trimmed its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 38.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,469 shares of the company’s stock after selling 2,155 shares during the period. Consolidated Planning Corp’s holdings in […]
Axxcess Wealth Management LLC grew its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 8.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 70,143 shares of the company’s stock after purchasing an additional 5,717 shares during the period. Axxcess Wealth Management LLC’s holdings […]
Abbrea Capital LLC decreased its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 2.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,962 shares of the medical research company’s stock after selling 47 shares during the period. Abbrea Capital LLC’s […]
Abbrea Capital LLC decreased its position in Lowe’s Companies, Inc. (NYSE:LOW – Free Report) by 1.4% in the fourth quarter, Holdings Channel.com reports. The firm owned 4,794 shares of the home improvement retailer’s stock after selling 70 shares during the quarter. Abbrea Capital LLC’s holdings in Lowe’s Companies were worth $1,067,000 as of its most […]
Anchor Capital Advisors LLC cut its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 21.4% during the 4th quarter, Holdings Channel.com reports. The firm owned 76,698 shares of the medical research company’s stock after selling 20,844 shares during the period. Anchor Capital Advisors LLC’s holdings in Bio-Rad Laboratories were worth $24,765,000 […]
U.S. Capital Wealth Advisors LLC trimmed its position in Verizon Communications Inc. (NYSE:VZ – Free Report) by 52.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 121,397 shares of the cell phone carrier’s stock after selling 135,720 shares during the […]
Victory Capital Management Inc. cut its holdings in shares of Salesforce, Inc. (NYSE:CRM – Free Report) by 1.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 636,183 shares of the CRM provider’s stock after selling 11,714 shares during the quarter. Victory […]
Cohen Capital Management Inc. lowered its holdings in shares of Berry Global Group, Inc. (NYSE:BERY – Free Report) by 0.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 89,423 shares of the industrial products company’s stock after selling 500 shares […]
Certuity LLC lifted its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 81.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,928 shares of the company’s stock after buying an additional 3,999 shares during the quarter. […]